CYN vs DOCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CYN

38.3
AI Score
VS
CYN Wins

DOCS

37.7
AI Score

Investment Advisor Scores

CYN

38score
Recommendation
SELL

DOCS

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CYN DOCS Winner
Forward P/E 0 19.1571 Tie
PEG Ratio 0 0.5895 Tie
Revenue Growth 328.3% 7.3% CYN
Earnings Growth 0.0% -51.9% CYN
Tradestie Score 38.3/100 37.7/100 CYN
Profit Margin 0.0% 25.5% DOCS
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

CYN 1M: -2.7% · 3M: -22.1% DOCS 1M: +23.9% · 3M: +30.6%

Current Technical Phase

CYN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.9%), weak momentum, RSI 45

RSI (14): 45.0 · Price: $1.09

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 58

RSI (14): 57.6 · Price: $25.33

Fundamentals Snapshot

Metric CYN DOCS
Market Cap
Forward P/E -0.8 15.6
Trailing P/E 30.5
Revenue (TTM)
Revenue Growth 3.3% 0.1%
Gross Margin 0.3% 0.9%
Operating Margin -46.8% 0.2%
EPS -0.29 0.85
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CYN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.